Outcomes in Patients With Severe West Nile Neuroinvasive Disease

被引:11
|
作者
Hawkes, Maximiliano A. [1 ]
Carabenciov, Ivan D. [1 ]
Wijdicks, Eelco F. M. [1 ]
Rabinstein, Alejandro A. [1 ]
机构
[1] Mayo Clin, Div Crit Care Neurol, Dept Neurol, Rochester, MN 55905 USA
关键词
acute flaccid paralysis; critical care; encephalitis; prognosis; West Nile virus; VIRUS-INFECTION; ENCEPHALITIS;
D O I
10.1097/CCM.0000000000003257
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To assess the long-term outcomes of patients hospitalized with severe West Nile neuroinvasive disease. Design: Retrospective cohort. Setting: Patients admitted to a referral center (Saint Mary's Hospital, Mayo Clinic). Participants: Twenty-six patients with West Nile neuroinvasive disease were identified by retrospective search of electronic database of Saint Mary's Hospital from January 1999 to November 2016. Interventions: Retrospective electronic medical records review and prospective telephone follow-up. Measurements and Main Results: Functional disability and cognitive outcomes were evaluated with the modified Rankin Scale and the Telephone Interview for Cognitive Status scores. Data on the time that the patient returned home after the hospitalization for West Nile neuroinvasive disease and the time of return to work were also collected. We identified 26 patients (81% males), 5917 years old. After a median hospital stay of 14.5 days (3-126), four patients died and 90% of survivors had a modified Rankin Scale of 3-5. Two additional patients died, and 80% of survivors had a modified Rankin Scale of 0-2 after a median follow-up of 73 months (1-144). Seven patients had cognitive impairment, which was severe in two of them. The combination of encephalitis and acute flaccid paralysis at presentation was associated with lower likelihood of returning home within 1 month after discharge (p < 0.01). Patients who required mechanical ventilation were more likely to have a modified Rankin Scale of 3-5 at last follow-up (p = 0.03), less likely to return home within 1 month of discharge (p < 0.01), less likely to return to their jobs (p < 0.01), and showed a trend toward having cognitive impairment (p = 0.05). Conclusions: Despite having poor outcomes at discharge, most West Nile neuroinvasive disease survivors with severe early disability can recover functional independence in the long term, justifying aggressive support during the acute phase and extensive rehabilitation efforts.
引用
收藏
页码:E955 / E958
页数:4
相关论文
共 50 条
  • [21] Emergence of West Nile virus lineage 2 in Europe: Characteristics of the first seven cases of West Nile neuroinvasive disease in horses in Austria
    de Heus, Phebe
    Kolodziejek, Jolanta
    Camp, Jeremy V.
    Dimmel, Katharina
    Bago, Zoltan
    Hubalek, Zdenek
    van den Hoven, Rene
    Cavalleri, Jessika-M. V.
    Nowotny, Norbert
    TRANSBOUNDARY AND EMERGING DISEASES, 2020, 67 (03) : 1189 - 1197
  • [22] Neuroinvasive West Nile Virus Disease in Canada. The Saskatchewan Experience
    Tellez-Zenteno, Jose F.
    Hunter, Gary
    Hernandez-Ronquillo, Lizbeth
    Haghir, Edrish
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2013, 40 (04) : 580 - 584
  • [23] A brief report of West Nile Virus neuroinvasive disease in the summer of 2012 in Hamilton, Ontario
    Jiao, Lei
    Main, Cheryl
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2014, 25 (01) : 24 - 26
  • [24] West Nile Neuroinvasive Disease Treated With High-Dose Corticosteroids
    Kal, Sarala
    Beland, Alexander
    Hasan, Mufadda
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (11)
  • [25] Clinical characteristics and functional outcome of patients with West Nile neuroinvasive disease in Serbia
    Natasa Popovic
    Branko Milosevic
    Aleksandar Urosevic
    Jasmina Poluga
    Nada Popovic
    Goran Stevanovic
    Ivana Milosevic
    Milos Korac
    Nikola Mitrovic
    Lidija Lavadinovic
    Jelena Nikolic
    Olga Dulovic
    Journal of Neurology, 2014, 261 : 1104 - 1111
  • [26] Human case of West Nile neuroinvasive disease in Portugal, summer 2015
    Ze-Ze, L.
    Proenca, P.
    Osorio, H. C.
    Gomes, S.
    Luz, T.
    Parreira, P.
    Fevereiro, M.
    Alves, M. J.
    EUROSURVEILLANCE, 2015, 20 (38): : 2 - 4
  • [27] Comorbid conditions as risk factors for West Nile neuroinvasive disease in Ontario, Canada: a population-based cohort study
    Sutinen, Jessica
    Fell, Deshayne B.
    Sander, Beate
    Kulkarni, Manisha A.
    EPIDEMIOLOGY AND INFECTION, 2022, 150
  • [28] Cauda equina arachnoiditis - a rare manifestation of West Nile virus neuroinvasive disease: A case report
    Santini, Marija
    Zupetic, Ivana
    Viskovic, Klaudija
    Krznaric, Juraj
    Kutlesa, Marko
    Krajinovic, Vladimir
    Polak, Vlatka Lovrakovic
    Savic, Vladimir
    Tabain, Irena
    Barbic, Ljubo
    Bogdanic, Maja
    Stevanovic, Vladimir
    Mrzljak, Anna
    Vilibic-Cavlek, Tatjana
    WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (17) : 3797 - 3803
  • [29] West Nile virus neuroinvasive disease associated with rituximab therapy
    Micaela Owens
    Lisa Choe
    Jose E. Rivera
    J. David Avila
    Journal of NeuroVirology, 2020, 26 : 611 - 614
  • [30] Neurological and neuromuscular manifestations in patients with West Nile neuroinvasive disease, Belgrade area, Serbia, season 2022
    Nikolic, Natasa
    Poluga, Jasmina
    Milosevic, Ivana
    Todorovic, Nevena
    Filipovic, Ana
    Jegorovic, Boris
    Mitrovic, Nikola
    Karic, Uros
    Gmizic, Ivana
    Stevanovic, Goran
    Milosevic, Branko
    NEUROLOGICAL SCIENCES, 2024, 45 (02) : 719 - 726